Enhanced accuracy in differential diagnosis of radiation necrosis by positron emission tomography-magnetic resonance imaging coregistration: Technical case report
A. Thiel et al., Enhanced accuracy in differential diagnosis of radiation necrosis by positron emission tomography-magnetic resonance imaging coregistration: Technical case report, NEUROSURGER, 46(1), 2000, pp. 232-234
OBJECTIVE AND IMPORTANCE: To demonstrate the usefulness of positron emissio
n tomography-magnetic resonance imaging (MRI) coregistration for differenti
ation of radiation necrosis and recurrent tumor in stereotactic planning.
CLINICAL PRESENTATION: T1-weighted MRI scans of a 43-year-old woman re veal
ed a contrast-enhancing lesion 4 years after open removal of a recurrent Fi
ght parieto-occipital Grade II oligodendroglioma and subsequent external ra
diation therapy. The suspected contrast-enhancing lesion revealed only mode
rate tracer uptake (1.3 times the uptake in the contralateral normal cortex
) in a coregistered [C-11]methionine positron emission tomographic scan. Ap
proximately 15 mm posterior and mesial to the center of the contrast-enhanc
ing lesion, however, an area of higher tracer uptake was found (1.8 times t
hat of the contralateral normal cortex), which exhibited only very minor co
ntrast enhance ment on MRI.
TECHNIQUE: The coregistered images were used for planning stereotactic seri
al biopsies, from the contrast-enhancing lesion as well as from the area wi
th higher methionine uptake. Histological examination demonstrated that the
contrast-enhancing lesion with low methionine uptake was necrotic tissue,
and the nonenhancing area with high methionine uptake was recurrent tumor,
CONCLUSION: High-resolution positron emission tomography and modern coregis
tration techniques allow differentiation of contrast enhancement and methio
nine uptake in irradiated brain tissue within small areas. High methionine
uptake is typical for recurrent tumor tissue and can be differentiated from
minor tracer accumulation resulting from disruption of the blood-brain bar
rier or macrophage activity within the necrotic area.